Amber C. King, Pharm.D., BCOP is a Medical Science Liaison and Associate Director at the Blueprint Medicines. She received her Doctor of Pharmacy degree in 2013 from Northeastern University in Boston, MA. She completed an ASHP-accredited PGY1 Pharmacy Residency at UT MD Anderson Cancer Center in Houston, TX, and an ASHP-accredited PGY2 Oncology Pharmacy Residency at Memorial Sloan Kettering Cancer Center. Her clinical interests include outcomes research in myeloproliferative neoplasms, myeloid leukemias, and lymphoid leukemias, guideline and treatment algorithm development, investigational protocol development, and mentorship of pharmacy residents and students.